Today’s Solutions: April 21, 2024

We recently wrote an article about why you should invest in all-electric gardening equipment. Recognizing the environmental and public health benefits of this transition, California has signed a bill into law that will ban the sale of new gas-powered leaf-blowers, lawnmowers, power washers, and other small off-road engines as early as 2024.

Using a gas-powered leaf blower for 30 minutes creates the same hydrocarbon emissions as driving 7,700 miles at a speed of thirty miles per hour. They also contribute to noise pollution and create health issues for those with extensive exposure to their exhaust. Not to mention that after the initial investment, electric tools save users an average of $200 due to lower maintenance and lack of fuel cost.

Once implemented, the law will not only end new gas-powered purchase options, but also offer customers rebates to purchase electric-powered replacements. Supporters of the bill have raised concerns over the timeline of the law which puts the ban at 2024 or “as soon as the state board determines is feasible, whichever is later.” Proponents also argue that the transition should be considered feasible by 2024 as half of California residents have already transitioned to cleaner equipment.

Solutions News Source Print this article
More of Today's Solutions

3 simple ways to save an extra $250 per month

Everyone loves to save money, so here are three easy ways you can free up $250 in your budget per month. Cancel subscriptions you ...

Read More

APA, AAPI, APIDA or AANHPI? The history and significance of the “Asian Americ...

“The journey of a thousand miles begins with one step.” ― Lao Tzu By Arielle Tiangco Weeks ago, seated cross-legged on my couch, I ...

Read More

Playing video games benefit key regions of the brain

A recent study from Georgia State University found that sensorimotor decision-making skills were superior in regular video game players to those that didn’t play ...

Read More

Novel blood cancer treatment effective in three-fourths of trial patients

According to new findings from an ongoing Phase 1/2 clinical research trial, a novel investigational immunotherapy resulted in successful response rates for 73 percent ...

Read More